The case for & against
Bull & Bear analysis
The Chemours Company (NYSE: CC) is a global leader in specialty chemicals and advanced materials, prominently recognized for its significant role in the chemical manufacturing value chain. The company's portfolio includes a range of high-performance products, including refrigerants, titanium dioxide, and other industrial chemicals, making it an essential participant in various industries such as automotive, construction, and electronics. In addition to its core operations, Chemours is steering its strategy toward sustainability, particularly through the introduction of low Global Warming Potential (GWP) refrigerants, aligning with global efforts to combat climate change and drive energy efficiency.
Bull says
- ↑Introduced low-GWP refrigerants targeting data center cooling under new regulations
- ↑Free cash flow up 128% to $114M in Q2, boosting liquidity
- ↑Declared Q2 dividend of $0.087/share (1.57% yield) for income investors
- ↑Adjusted EBITDA of $247M (-5% YoY, +46% sequentially) shows operational resilience
- ↑High oil sensitivity may drive revenue upside as energy prices rise
- ↑Strong momentum and below-value trading signal potential stock recovery
Bear says
- ↓Very weak profitability metrics; Q2 margins pressured by lower volumes
- ↓High leverage may constrain growth investments and strategic flexibility
- ↓Q2 net sales fell 1% YoY to $1.59B, signaling soft demand
- ↓Stock down 38.7% over 90 days; UBS cut target to $18
- ↓Negative growth trends heighten value-trap concerns
- ↓Weak revision metrics suggest eroding analyst confidence
Investment themes with CC
Companies paying above-average dividends
Earnings Call · Q1 2024 · Mgmt. Guidance
Transcript signals
Bull points
- Adjusted EBITDA for TT was better than expected for 3 primary reasons: our actions to allocate TiO2 volumes to higher yield regions, more favorable than expected timing of lower cost or consumption, and our transformation plan continuing to produce strong results.
- For now, we're going to continue to provide an outlook for the quarter ahead. On a consolidated basis, we expect net sales to increase approximately 15% sequentially in the second quarter with consolidated adjusted EBITDA growing in line also up approximately 15%.
- We anticipate adjusted EBITDA for TT growing in line with the sequential increase in net sales.
Bear points
- Consolidated adjusted EBITDA decreased 37% year-over-year from $304 million to $193 million. This decrease was primarily driven by demand weakness combined with lower cost absorption in APM and a slower start to 2024 in TSS, partially offset by the cost out actions in TT that Denise just mentioned.
- Consolidated net income was $52 million compared with $145 million in the prior year quarter. Net income per diluted share was $0.34 compared with $0.96 in the prior year quarter.
- We expect corporate expenses to be higher in the second quarter by approximately $15 million to $20 million sequentially. This range primarily reflects a normalization of expenses associated with the company's long-term incentive plan and environmental remediation costs.